<DOC>
	<DOCNO>NCT00669656</DOCNO>
	<brief_summary>This study Prostate Health Cocktail , combination supplement contain vitamin D3 , vitamin E , selenium , green tea extract , saw palmetto , lycopene , soy derivative . This product currently available market , herb vitamin supplement regulate FDA . Each ingredient study prostate cancer cell and/or patient prostate cancer . At dos include supplement , serious side effect report . The purpose study find whether Prostate Health Cocktail low PSA . Additionally , look see whether take treatment cause unexpected side effect , whether certain blood test inform u disease status addition PSA</brief_summary>
	<brief_title>Herbal Therapy Treatment Recurrent Prostate Cancer</brief_title>
	<detailed_description>Objectives study : - To assess PSA response prostate cancer patient PSA-only disease recurrence curative local therapy , treatment combination herbal supplement . - To qualitatively quantitatively describe toxicity profile herbal supplement . - To assess change PSA double time subject treat supplement . - To measure tissue GRP78 , serum neuroendocrine marker , circulate tumor cell , correlation treatment response prostate cancer outcome</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>: Age great equal 18 Histologically document adenocarcinoma prostate Initial treatment radical prostatectomy external beam radiation Neoadjuvant/Adjuvant Androgen Deprivation therapy allowable , provide maximum 24 month , last dose medication least 12 month previously Neoadjuvant adjuvant chemotherapy allowable , provide maximum 6 month , last dose medication least 12 month previously Adjuvant radiation radical prostatectomy allow , provide least 6 month elapse completion radiation enrollment study PSA recurrence , rise PSA , define : Post Radiation Therapy : Absolute PSA &gt; 2.0 ng/mL PSA nadir &lt; 4 ng/mL radiation Absolute rise least 0.5 ng/mL total At least 2 increase PSA , separate least 2 week ; separate PSA value decline provide second rise value high first rise value . Post Prostatectomy : Absolute PSA &gt; 1.0 ng/mL Absolute rise least 1 ng/mL total nadir At least 2 increase PSA separate least 2 week ; separate PSA value decline provide second rise value high first value PSA Doubling Time ( PSA DT ) 3 month le 36 month PSA DT calculate use webbased calculator http : //kevin.phys.unm.edu/psa/ follow constraint : At least 3 value , 6 All value must &gt; 0.2 Values must separate least 2 month No radiographically evident bony soft tissue metastasis Documented discussion subject physician option pursue hormone therapy and/or salvage local therapy rather enroll study Patients receive treatment androgen deprivation biochemical recurrence eligible provide : They document castration resistance ( define 2 rise PSA value testosteron &lt; 50 They androgen deprivation least 3 month recover testosterone ( &gt; 150 ) They decide , conjunction treat physician want resume androgen deprivation ECOG Performance Status 02 Life expectancy &gt; 12 month Adequate hepatic function ( AST , ALT , bilirubin &lt; 1.5 x ULN ) Adequate renal function ( eGFR CockcroftGault comparable calculation &gt; 50 ml/min ) Willing discontinue nutritional supplement 5alpha reductase inhibitor ( finasteride , dutasteride ) duration study treatment , unless medication use control symptom BPH patient take medication 6 week Willing discontinue weight control medication duration study treatment Signed informed consent Atypical prostate carcinoma histology ( ex : small cell , adenoid cystic ) Evidence bony soft tissue metastatic disease CT/MRI bone scan PET/CT Other invasive malignancy within prior 3 year , except fully treat basal cell squamous cell carcinoma skin . Fulldose anticoagulation therapy ( warfarin low molecular weight heparin ) antiplatelet therapy ( clopidogrel ticlopidine ) , exception lowdose aspirin therapy ( 81 mg ) . Significant cardiac disease , include limited angina , myocardial infarction , cardiomyopathy , congestive heart failure , coronary artery disease require bypass surgery , angioplasty stent placement . Significant uncontrolled comorbid condition , opinion treat physician would compromise subject 's ability comply protocol requirement , would pose undue risk experience adverse event .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>